Berger, S. C., Sommermeyer, D., Hudecek, M., Berger, M., Balakrishnan, A., Paskiewicz, P., . . . Riddell, S. (2014). Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model. J Immunother Cancer.
Citação norma ChicagoBerger, S Carolina, Daniel Sommermeyer, Michael Hudecek, Michael Berger, Ashwini Balakrishnan, Paulina Paskiewicz, Paula Kosasih, Christoph Rader, and Stanley Riddell. "Safety of Targeting ROR1 for Cancer Immunotherapy With Chimeric Antigen Receptor-modified T Cells in a Primate Model." J Immunother Cancer 2014.
ציטוט MLABerger, S Carolina, et al. "Safety of Targeting ROR1 for Cancer Immunotherapy With Chimeric Antigen Receptor-modified T Cells in a Primate Model." J Immunother Cancer 2014.